Crossmark

Controllable Factors to Reduce the Rate of Complications in Primary Breast Augmentation: A Review of the Literature

Published Online: 2020-05-01

Published Print: 2021-04

Authors

Montemurro, Paolo

Hedén, Per

Behr, Björn

Wallner, Christoph
License Information

Text and Data Mining valid from 2020-05-01

Version of Record valid from 2020-05-01
More Information

Article History

Received: 14 November 2019

Accepted: 9 April 2020

First Online: 1 May 2020

Compliance with Ethical Standards

:

: Dr. Montemurro is a consultant and speaker for Allergan, Inc. (Irvine, CA). Dr. Hedén is a consultant and speaker for Allergan, Inc., Establishment Labs Co, G&G Medical, GC Aesthetics, Johnsson & Johnsson (Irvine, Calif.) and an unpaid consultant for Canfield Scientific (Fairfield, N.J.). The other authors declared no potential conflicts of interest with respect to the research, authorship and publication of this article.

: This article does not contain any studies with human participants or animals performed by any of the authors.

: For this type of study, informed consent is not required.

Document is current